Johnson & Johnson Impella Heart Pump Malfunction Lawsuit Lawyers

FDA Class I Recalls Warn That Malfunctioning Pressure Sensors May Display Inaccurate Information During Critical Heart Failure Treatment

What Parker Waichman LLP Found

• FDA finalized Class I recalls involving Impella RP heart pump devices.
• The dP sensor may malfunction and cause inaccurate controller readings.
• The issue has been associated with 22 reported patient injuries.
• Affected patients may need medical record review to determine whether inaccurate readings contributed to harm.
• Lawsuits may focus on product defect, failure to warn, delayed correction, and preventable patient injury.

The FDA has finalized multiple Class I recalls involving Johnson & Johnson MedTech’s Impella RP heart pump devices, including Impella RP, Impella RP with SmartAssist, and Impella RP Flex with SmartAssist. These devices are used for patients facing acute right heart failure, meaning they may be used during extremely serious medical situations where accurate device information can affect clinical decisions. The recall does not require hospitals to return the devices, but it does require updated instructions for use because the FDA warned that using the affected devices without following the updated instructions may cause serious injury or death.

The issue involves the differential pressure, or dP, sensor. According to FDA recall records, the dP sensor in Impella RP devices may malfunction, causing sensor values to drift. When that happens, the Automated Impella Controller may display inaccurate information. This matters because clinicians may rely on controller readings when assessing pump position, flow, patient status, and whether intervention is needed.

This recall is especially serious because it involves patients who may already be medically fragile. A patient receiving right-heart support may be in an intensive care setting, recovering from a cardiac event, or dependent on careful monitoring. If displayed information is inaccurate, a medical team may make a treatment decision based on incorrect device data.

Why The FDA Classified The Impella Recall As Class I

A Class I recall is the FDA’s most serious recall category. The FDA stated that the updated instructions are necessary because continued use without the updated guidance may result in serious injury or death.

Unlike a traditional product recall where a device is removed from use, this recall is a correction. That means hospitals and medical providers may continue using affected devices, but they must follow revised safety instructions. This type of recall can still support legal claims if a patient was harmed before the warning, before updated instructions were followed, or because inaccurate device readings contributed to unnecessary treatment, delayed treatment, or injury.

The affected recalls reportedly include 4,496 Impella RP Flex with SmartAssist devices, 291 Impella RP with SmartAssist devices, and 179 Impella RP devices. ([Cardiovascular Business][3]) The FDA and medical reporting sources have linked the issue to 22 patient injuries, with no reported deaths tied to this specific sensor issue as of the published reports.

What Went Wrong With The Impella Pressure Sensor

The core concern is sensor drift. A pressure sensor should provide reliable readings during device operation. If the sensor values drift over time, the controller may show data that does not accurately reflect the patient’s condition or the device’s performance.

Reports indicate that inaccurate display information may include pump flow readings, pulmonary artery placement signals, pulmonary artery pulsatility index, and central venous placement signals. These are not minor data points. They can influence how clinicians interpret whether the pump is positioned correctly, whether the patient is improving, whether the device is functioning as expected, and whether intervention is required.

Johnson & Johnson MedTech has stated that the sensor issue does not affect the pump’s ability to provide hemodynamic support. However, that does not eliminate the danger. A device can still pump while inaccurate readings lead to improper decisions. In a critical care setting, wrong information can be dangerous even when the mechanical support function continues.

How Inaccurate Impella Readings May Harm Patients

Patients may be harmed when inaccurate device data causes a treatment team to make choices it would not have made with accurate information. The reported concern is not simply that a number appears wrong on a screen. The concern is that inaccurate readings can influence clinical intervention.

Possible consequences may include unnecessary pump exchange, repositioning procedures, delayed recognition of a true device or patient problem, unnecessary testing, medication changes, or extended hospitalization. MedTech Dive reported that erroneous information on the controller had caused inaccurate adjustments and unnecessary pump exchanges, according to the FDA’s early alert.

For a critically ill patient, unnecessary procedures can carry serious risk. Repositioning or exchanging a heart pump may expose a patient to bleeding, vascular injury, infection, anesthesia risks, clotting complications, or worsening cardiac instability. Delayed intervention can also be dangerous if inaccurate readings mask a real problem.

Which Impella Devices Are Included In The Recall?

The FDA recall involves the following Impella right-heart support devices:

• Impella RP
• Impella RP with SmartAssist
• Impella RP Flex with SmartAssist

These devices are designed to provide support for patients with acute right heart failure. The issue is tied to differential pressure sensors in Impella RP devices. Reporting indicates that Impella 5.5 and Impella CP devices are not included in this specific sensor-related alert because they do not use the same dP sensor at issue.

Patients and families may not know which device was used during hospitalization. Medical records, operative notes, ICU notes, device logs, and hospital billing records may help identify the product, model, timing of use, alarms, controller readings, and whether complications occurred.

Signs A Patient Or Family Should Review A Possible Impella Claim

A patient or family may want to review a possible claim if an Impella RP device was used and the patient experienced unexplained complications, additional procedures, or a sudden change in care. Not every poor outcome means there is a lawsuit. However, this recall creates a reason to investigate whether device data played a role.

Potential warning signs include a sudden pump adjustment, pump repositioning, pump exchange, unexpected cardiac decline, unexplained hemodynamic instability, prolonged ICU stay, vascular complications, bleeding, infection, stroke, organ injury, or worsening heart failure after device use.

Families should request and preserve medical records as soon as possible. Important records may include ICU flow sheets, nursing notes, cardiology notes, catheterization lab reports, device console data, imaging reports, adverse event notes, discharge summaries, and billing records identifying the device.

Legal Claims That May Apply In An Impella Heart Pump Recall Lawsuit

A medical device lawsuit may involve several legal theories. A product liability claim may argue that the device was defective, unsafe for its intended use, or failed to perform as reasonably expected. A failure-to-warn claim may argue that patients, hospitals, or clinicians were not adequately warned about the risk of inaccurate readings soon enough.

A negligence claim may examine whether the manufacturer properly tested the device, monitored field reports, investigated complaints, updated warnings, and communicated risks. If earlier reports showed a pattern of sensor problems, plaintiffs may argue that stronger warnings or corrective action should have occurred sooner.

Damages may include medical bills, additional hospitalization, rehabilitation, lost income, pain and suffering, diminished quality of life, permanent injury, and wrongful death damages when applicable. Because these devices are used in high-risk cardiac patients, causation must be carefully evaluated through medical records and device-specific evidence.

Lawsuit FAQs About The Johnson & Johnson Impella Recall

Can I File A Lawsuit If I Was Injured After Receiving An Impella Heart Pump?

You may be able to file a lawsuit if an affected Impella RP device was used during your care and you suffered injuries connected to inaccurate readings, unnecessary intervention, delayed treatment, or device-related complications. The key issue is whether the device problem contributed to the harm. Medical records are critical because they may show controller readings, clinical decisions, pump adjustments, and complications during treatment.

What If The Device Was Not Removed From The Market?

A recall does not have to involve product removal to support a legal claim. The FDA described this recall as an instruction update, not a device removal. However, the recall was still classified as Class I, the most serious type. A patient may still have a claim if the device displayed inaccurate information and that information contributed to injury.

What Injuries May Be Connected To An Impella Recall Claim?

Potential injuries may include complications from unnecessary pump exchange, vascular injury, bleeding, infection, worsening heart failure, prolonged hospitalization, cardiac instability, organ injury, or other serious harm. Each case depends on the patient’s condition, the device used, and the medical decisions made during treatment.

What Evidence Is Needed For An Impella Heart Pump Lawsuit?

Important evidence may include hospital records, device records, ICU notes, catheterization lab reports, imaging, operative notes, adverse event documentation, discharge summaries, and billing records identifying the device model. Family members should also keep written timelines, names of hospitals and treating physicians, and any communication received about the recall.

How Long Do Patients Or Families Have To File A Claim?

Deadlines vary by state and by the facts of the case. Some deadlines may begin when the injury occurred, while others may involve when the patient reasonably discovered the connection between the injury and the device. Because medical device cases are time-sensitive, affected patients and families should seek a legal review as soon as possible.

Contact Parker Waichman LLP For A Free Case Review

Patients and families affected by Johnson & Johnson Impella RP heart pump complications may have legal options. If an Impella RP, Impella RP with SmartAssist, or Impella RP Flex with SmartAssist device was used during treatment and serious injury followed, Parker Waichman LLP can review the facts.

Parker Waichman LLP offers free consultations for patients and families nationwide. Call 1-800-YOUR-LAWYER (1-800-968-7529) today to discuss a potential Impella heart pump recall lawsuit. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.